Larbig Gregor, Schmidt Boris
Darmstadt Technical University, Clemens Schöpf-Institute for Organic Chemistry and Biochemistry, Petersenstrasse 22, D-64287 Darmstadt, Germany.
J Comb Chem. 2006 Jul-Aug;8(4):480-90. doi: 10.1021/cc0600021.
The aspartic protease beta-secretase (BACE-1) is an attractive target for the therapy of Alzheimer's disease. The known inhibitors share a high analogy to the substrate peptide and, thus, display undesired pharmacological properties. Compact nonpeptidic lead structures are scarce. Here, we report the activities of tetronic and tetramic acids on BACE-1 inhibition. The compounds feature a low molecular weight and compact scaffold, which is accessible by solid-phase-supported diverse synthesis.
天冬氨酸蛋白酶β-分泌酶(BACE-1)是治疗阿尔茨海默病的一个有吸引力的靶点。已知的抑制剂与底物肽具有高度相似性,因此表现出不良的药理特性。紧凑的非肽类先导结构很少见。在此,我们报道了特窗酸和四嗪酸对BACE-1抑制的活性。这些化合物具有低分子量和紧凑的骨架,可通过固相支持的多样合成获得。